Qube Research & Technologies LTD Valneva Se Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Valneva Se stock. As of the latest transaction made, Qube Research & Technologies LTD holds 22 shares of VALN stock, worth $140. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22
Previous 22
-0.0%
Holding current value
$140
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding VALN
# of Institutions
12Shares Held
653KCall Options Held
0Put Options Held
0-
General American Investors CO Inc354KShares$2.26 Million0.17% of portfolio
-
Wells Fargo & Company San Francisco, CA183KShares$1.17 Million0.0% of portfolio
-
Alpha Centric Advisors LLC San Juan, PR88.3KShares$563,0470.51% of portfolio
-
Ironwood Investment Management LLC Boston, MA25KShares$159,6400.1% of portfolio
-
Morgan Stanley New York, NY1.98KShares$12,6260.0% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $441M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...